|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
Hathaway Corporation Wholly Owned Subsidiary, Diabetes Detection, Inc., Develops Medical Device to Detect Neuropathy Deficiencies Currently Affecting Over 21 Million Americans and Millions More Globally
8/13/2007 11:38:33 AM
PALO ALTO, CA -- 08/07/07 -- Hathaway Corporation (PINKSHEETS: HWYI), a company that focuses on acquiring, developing, and managing disruptive technologies in the telecommunications, medical devices and software fields, announced that their wholly owned subsidiary DDI has, in conjunction with Daviscomms (S), Ltd, announced the company has developed a pager with DDI's patent-pending vibration technology and will utilize the pager to begin clinical trials in testing diabetic patients for neuropathy deficiencies.
|
|
|
|
|
|
|
|
|
|
|